Search results
There is a page named "Anti-obesity drug" on Wikipedia
genetic conditions that cause obesity. It is less effective and not approved for general obesity. Some weight loss drugs act on the neurotransmitters serotonin...53 KB (4,991 words) - 05:08, 21 July 2024
Orlistat (redirect from Alli (drug))stability, orlistat was chosen over lipstatin for development as an anti-obesity drug. The effectiveness of orlistat in promoting weight loss is definite...39 KB (3,466 words) - 10:08, 22 May 2024
Semaglutide (category Drugs with non-standard legal status)antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. It is a peptide similar...66 KB (5,434 words) - 17:03, 8 August 2024
Naltrexone/bupropion (category Anti-obesity drugs)physical activity, as anti-obesity medication for the management of weight in adults with an initial body mass index (BMI) of: 30 kg/m2 (obese), or 27 kg/m2 to...21 KB (1,593 words) - 01:57, 16 July 2024
Fenfluramine/phentermine (category Combination anti-obesity drugs)The drug combination fenfluramine/phentermine, usually called fen-phen, was an anti-obesity treatment in the early 1990s that utilized two anorectics...20 KB (2,185 words) - 07:38, 6 April 2024
Sibutramine (category Withdrawn anti-obesity drugs)of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action". Obesity Reviews. 1 (2): 127–139. doi:10.1046/j.1467-789x...39 KB (3,518 words) - 09:36, 9 May 2024
Rimonabant (category Withdrawn anti-obesity drugs)anti-obesity treatment for approval. The application was deemed not-approvable by FDA, and the company cancelled plans for a re-submission. The drug was...14 KB (1,176 words) - 20:07, 10 March 2024- Cagrilintide/semaglutide (category Combination anti-obesity drugs)June 2023). "Approved Anti-Obesity Medications in 2022 KSSO Guidelines and the Promise of Phase 3 Clinical Trials: Anti-Obesity Drugs in the Sky and on the...6 KB (422 words) - 13:41, 6 August 2024
- Bariatric surgery (redirect from Obesity surgery)surgery) is a medical term for surgical procedures used to manage obesity and obesity-related conditions. Long term weight loss with bariatric surgery...67 KB (7,795 words) - 18:37, 6 August 2024
Phenylpropanolamine (category Anti-obesity drugs)Tonkin AM, McNeil JJ (2006). "Safety of drug therapies used for weight loss and treatment of obesity". Drug Saf. 29 (4): 277–302. doi:10.2165/00002018-200629040-00001...51 KB (5,502 words) - 23:47, 3 August 2024
Orforglipron (category Experimental anti-obesity drugs)1056/NEJMoa2302392. PMID 37351564. Sidik, Saima (2023). "Beyond Ozempic: brand-new obesity drugs will be cheaper and more effective". Nature. 619 (7968): 19. Bibcode:2023Natur...3 KB (184 words) - 13:53, 14 June 2024- Rights to Alvogen in Korea for Anti-Obesity Drug". 6 September 2017. Letter, The Pharma. "Alvogen adds Qsymia to its anti-obesity portfolio in South Korea"...11 KB (914 words) - 20:13, 22 June 2024
Phentermine/topiramate (category Anti-obesity drugs)under the brand name Qsymia, is a combination drug of phentermine and topiramate used to treat obesity. It is used together with dietary changes and exercise...10 KB (941 words) - 05:50, 2 July 2024- Survodutide (category Experimental anti-obesity drugs)preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy". Molecular Metabolism. 66: 101633. doi:10.1016/j.molmet.2022...7 KB (207 words) - 18:46, 16 June 2024
- GLP-1 receptor agonist (redirect from GLP-1 drug)body weight, making them an effective treatment for obesity. Another class of anti-diabetes drugs, the DPP-4 inhibitors, work by reducing the breakdown...37 KB (3,890 words) - 03:08, 12 August 2024
Phentermine (category Anti-obesity drugs)Diethylproprion: Sympathomimetic Drugs in the Management of Obesity". In Bray GA, Bouchard C (eds.). Handbook of Obesity - Volume 2 Clinical Applications...20 KB (1,714 words) - 14:14, 6 August 2024- lifespan in healthy laboratory mice. Rimonabant (Acomplia) is an anti-obesity drug initially approved for use in the European Union but later withdrawn...23 KB (2,847 words) - 12:04, 25 March 2024
Monlunabant (category Experimental anti-obesity drugs)metabolic syndrome. A randomized, placebo-controlled, double-blind phase 1b study". Diabetes, Obesity and Metabolism. doi:10.1111/dom.15353. PMID 37941317....5 KB (286 words) - 01:39, 16 August 2024
2,4-Dinitrophenol (category Withdrawn anti-obesity drugs)weight loss drug due to its dangerous side effects, its mechanism of action remains under investigation as a potential approach for treating obesity and non-alcoholic...35 KB (3,728 words) - 18:23, 1 August 2024
Tesofensine (category Experimental anti-obesity drugs)reuptake inhibitor from the phenyltropane family of drugs, which is being developed for the treatment of obesity. Tesofensine was originally developed by a Danish...16 KB (1,763 words) - 20:54, 16 August 2024
- Willyard, “How anti-ageing drugs could boost COVID vaccines in older people”, Nature, (14 October 2020), 586, pp.352-354 Carolyn Bramante, an obesity researcher
- engaged in making or selling 'obesity cures,' and consists in the main of a list of supposed producers and selles of 'anti-fat remedies' compiled from the
- adrenaline and were used to treat narcolepsy during WWII and depression and obesity in the 50’s and 60’s Antacids - simple bases, such as metal oxides, hydroxides